Skip to main content
. 2013 Nov 20;79(1):85–96. doi: 10.1111/bcp.12287

Figure 2.

Figure 2

Screen captures of prototype tarcrolimus dashboard showing (A) overlays of tacrolimus concentration with user-selected biomarkers Inline graphic, TAC; Inline graphic, SRCR; Inline graphic, ALT and (B) concentration–time course relative to dose adjustments and the occurrence of adverse events. Inline graphic, TAC; Inline graphic, DOSE; Inline graphic, CLIN_EVENT